FDA clears Vivos Therapeutics' oral device for sleep apnea

By Reuters
| November 30, 2023

Vivos Therapeutics says the FDA has cleared its oral device for severe obstructive sleep apnea, leading a massive rally in the company's shares before the bell.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...